Lonard David M, Lanz Rainer B, O'Malley Bert W
Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Endocr Rev. 2007 Aug;28(5):575-87. doi: 10.1210/er.2007-0012. Epub 2007 Jul 3.
Nuclear receptor (NR) coregulators (coactivators and corepressors) are essential elements in regulating nuclear receptor-mediated transcription. In a little more than a decade since their discovery, these proteins have been studied mechanistically and reveal that the regulation of transcription is a highly controlled and complex process. Because of their central role in regulating NR-mediated transcription and in coordinating intercompartmental metabolic processes, disruptions in coregulator biology can lead to pathological states. To date, the extent to which they are involved in human disease has not been widely appreciated. In a complete literature survey, we have identified nearly 300 distinct coregulators, revealing that a great variety of enzymatic and regulatory capabilities exist for NRs to regulate transcription and other cellular events. Here, we substantiate that coregulators are broadly implicated in human pathological states and will be of growing future interest in clinical medicine.
核受体(NR)共调节因子(共激活因子和共抑制因子)是调节核受体介导转录的关键要素。自发现这些蛋白质至今的十多年间,对其进行了机制研究,结果表明转录调控是一个高度受控且复杂的过程。由于它们在调节NR介导的转录以及协调细胞间代谢过程中发挥核心作用,共调节因子生物学功能的破坏可导致病理状态。迄今为止,它们在人类疾病中的参与程度尚未得到广泛认识。通过全面的文献调研,我们已识别出近300种不同的共调节因子,这表明NR具有多种多样的酶促和调节能力来调控转录及其他细胞事件。在此,我们证实共调节因子广泛涉及人类病理状态,并且在未来临床医学中将越来越受关注。